BERLIN Bayer shares jumped on Thursday after it revealed plans aimed at resolving multi-billion dollar lawsuits linked to glyphosate, a move welcomed by activist shareholder Elliott, which has taken a sizeable stake in the chemicals company.
Frankfurt BASF-Chef Martin Brudermüller macht Ernst: Im Herbst kündigte er ein Sparprogramm an, nun kommt der Abbau von weltweit 6000 Stellen.
BERLIN BASF will cut 6,000 jobs worldwide, mainly involved in its central administration, in a move it said will achieve annual savings of 300 million euros ($341 million) from 2021 and give more power to customer-facing executives.
LONDON GlaxoSmithKline (GSK) has kicked off the sale of some consumer health brands as it seeks to raise about 1 billion pounds ($1.26 billion) before pressing ahead with a spinoff of its consumer healthcare business, sources told Reuters.
LONDON Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain's largest drugmaker told Reuters.
Frankfurt Nach Manager-Schelte, Kursverfall und einer Klagewelle in den USA versucht Bayer, wieder in die Offensive zu kommen:
FRANKFURT Germany's Bayer sought to repair its reputation on Friday after damage caused by U.S. litigation over claims its glyphosate pesticide causes cancer, saying it would invest 5 billion euros ($5.6 billion) in weedkiller research.
British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of California, in a boost to its prospects for developing new drugs.
FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.